The role of the short‐pulsed 1064‐nm‐Nd:YAG laser in treating onychomycosis has been the subject of controversial discussion ever since it received FDA approval in 2010. Research to date provides no… Click to show full abstract
The role of the short‐pulsed 1064‐nm‐Nd:YAG laser in treating onychomycosis has been the subject of controversial discussion ever since it received FDA approval in 2010. Research to date provides no valid conclusions supporting its use from an evidence‐based perspective.
               
Click one of the above tabs to view related content.